eWatch - Extensive Personal Monitoring & Watch Platform
From 01-09-2016 to 31-08-2019
Description
The ageing population and related increase in chronic diseases put considerable pressure on both the healthcare system and the society, resulting in an unsustainable rise of healthcare costs. Each year over 4 million deaths are caused by cardiac diseases only throughout the world. More than 100 million can conduct their life after a heart attack and there are 30 million of people who suffer from arrhythmia and other cardiac and cardiovascular disorders according to the WHO – World Health Organization, 2014. The cost for treatments associated with these diseases is about 650 billion per year.
Wearable health monitoring systems provide a big promise in allowing individuals to closely monitor changes in her or his vital signs and provide feedback to regain or maintain an optimal health status. Monitoring hearth rate, blood pressure and blood glucose, oxygen saturation, physical activity and other physiological parameters will minimize the treatment cost and enhance the quality of life.
The overall goal of the eWatch project is to provide an extensive human centric, personal monitoring platform.
Team
- Sabine Van Huffel, Promoter
- Steven Vandeput, Team member
Financing
Funding: IWT - Agentschap voor Innovatie door Wetenschap en Technologie
Program/Grant Type: IWT O&O - IWT Industrial R&D projects
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.